期刊文献+

Survivin在类风湿关节炎中的表达及意义 被引量:2

Expression of survivin in rheumatoid arthritis
下载PDF
导出
摘要 目的:探讨存活素(survivin)与类风湿关节炎(RA)发生发展的关系,以及与难治性类风湿关节炎(RRA)多药耐药的相关性。方法:按照入组标准收集正常人15例、RA初诊未治组35例,治疗有效组20及难治组25例。采用免疫细胞化学法检测外周血淋巴细胞上survivin的表达。结果:外周血淋巴细胞中survivin阳性表达率RA初诊未治组明显升高,与正常对照组相比差异有统计学意义(χ2=29.59,P<0.01);RA治疗有效组稍有升高,与正常对照组相比差异无统计学意义(χ2=1.591,P>0.05);RA难治组明显升高,与正常对照组(χ2=26.53,P<0.01)和RA治疗有效组(χ2=24.35,P<0.01)相比差异均有统计学意义,与初诊未治组比差异无统计学意义(χ2=0.014,P>0.05)。结论:Survivin可能参与了类风湿关节炎的发病过程,可能参与难治性RA多药耐药,是难治性RA多药耐药形成机制之一。 To detect the correlation between survivin and rheumatoid arthritis (RA) to determine the possible mechanism of RA and multidrug resistance in refractory rheumatoid arthritis (RRA). Methods: We collected 15 normal controls, 35 early untreated RA patients, 20 effectively treated RA patients and 25 RRA patients according to selection standard. The expression of survivin in the peripheral blood lymphocytes was detected by immunocytochemical method.Results: There was significant difference in the survivin expression in the peripheral blood lymphocytes between the early untreated and normal control group (χ2=29.59, P〈0.01). The survivin expression in the peripheral blood lymphocytes of effectively treated RA group slightly elevated, but had no significant difference with the normal control group (χ2=1.591, P〉0.05). The survivin expression in the peripheral blood lymphocytes of the RRA group was significantly stronger than in the effectively treated RA group (χ2=24.35, P〈0.01), and normal control group (χ2=26.53, P〈0.01), with no significant difference compared with early untreated group (χ2=0.014,P〉0.05). Conclusion: Survivin has an influential role in the occurrence and development of rheumatism arthritis. Survivin might be involved in refractory multidrug resistance of RA and be one of the multidrug resistance mechanism of RRA.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2013年第2期186-190,共5页 Journal of Central South University :Medical Science
基金 国家自然科学基金(81172850)~~
关键词 类风湿关节炎 多药耐药 存活素 rheumatoid arthritis (RA) multidrug resistance (MDR) survivin
  • 相关文献

参考文献16

  • 1Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene Survivin expressed in cancer and lymphoma[J]. Nat Med, 1997, 3(8): 917-921.
  • 2Altieri DC. Survivin, cancer networks and pathway-directed drug discovery[J]. Nat Rev Cancer, 2008, 8 (1): 61-70.
  • 3Frank A, Sibylla M, Shida Y, et al. Inflammation-associated cell cycle in dependent block of apoptosis by survivin interminally differentiated neutrophils [J]. Exp Med, 2004, 199 (1 O): 1343-1354.
  • 4Cheung CH, Chen HH, Kuo CC, et al. Survivin counteracts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers[J]. Mol Cancer, 2009, 8(1): 43.
  • 5任彬,杨敏.云克治疗难治性类风湿性关节炎32例临床观察[J].黑龙江医学,2008,32(12):928-929. 被引量:6
  • 6Kurosaka D, Hirai K, Nishioka M, et al. Correlation between synovial blood flow signals and serum vascular endothelial growth factor levels in patients with refractory rheumatoid arthritis[J]. Mod Rheumatol, 2009,19(2): 187-191.
  • 7Starovskaya AA. Cellar mechanisms of multidrug resistance of tumor cells [J]. Biochemistry (Mosc), 2000, 65 (1): 95-106.
  • 8刘继红,李卫东,林志彬.类风湿关节炎细胞凋亡的研究现状[J].中国临床药理学与治疗学,2003,8(2):232-236. 被引量:18
  • 9Isgren A, Forslind K, Erlandsson M, et al. High survivin levels predict poor clinical respense to infliximab in patients with rheumatoid arthritis[J]. Semin Arthritis Rheum, 2012, 41(5): 652-657.
  • 10Yin Oa Shen J, Chen L, et al. Overcoming muttidrug resistance by 10-delivery of Mdr-1 and survivin-targeting RNA with reduction- responsible cationia poly ([3-amino esters)[J]. Biomaterials, 2012, 33(27): 6495-6506.

二级参考文献3

共引文献22

同被引文献26

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部